Clinical trials into potential heart drug halted over Brexit fears

California-based research firm Recardio was due to begin a study of the drug dutogliptin on patients in Exeter, Leeds and Clydebank. However, it has now suspended the UK arm of the trial. (stock)
Source: the Mail online | Health - Category: Consumer Health News Source Type: news